BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22359113)

  • 1. Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk.
    Matsunobu A; Imai R; Kamada T; Imaizumi T; Tsuji H; Tsujii H; Shioyama Y; Honda H; Tatezaki S;
    Cancer; 2012 Sep; 118(18):4555-63. PubMed ID: 22359113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of carbon ion radiotherapy for primary spinal sarcoma.
    Matsumoto K; Imai R; Kamada T; Maruyama K; Tsuji H; Tsujii H; Shioyama Y; Honda H; Isu K;
    Cancer; 2013 Oct; 119(19):3496-503. PubMed ID: 23939877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon ion radiotherapy for unresectable sacral chordomas.
    Imai R; Kamada T; Tsuji H; Yanagi T; Baba M; Miyamoto T; Kato S; Kandatsu S; Mizoe JE; Tsujii H; Tatezaki S;
    Clin Cancer Res; 2004 Sep; 10(17):5741-6. PubMed ID: 15355901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas.
    Serizawa I; Kagei K; Kamada T; Imai R; Sugahara S; Okada T; Tsuji H; Ito H; Tsujii H
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1105-10. PubMed ID: 19467578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas.
    Kamada T; Tsujii H; Tsuji H; Yanagi T; Mizoe JE; Miyamoto T; Kato H; Yamada S; Morita S; Yoshikawa K; Kandatsu S; Tateishi A;
    J Clin Oncol; 2002 Nov; 20(22):4466-71. PubMed ID: 12431970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon ion radiotherapy for localized primary sarcoma of the extremities: results of a phase I/II trial.
    Sugahara S; Kamada T; Imai R; Tsuji H; Kameda N; Okada T; Tsujii H; Tatezaki S;
    Radiother Oncol; 2012 Nov; 105(2):226-31. PubMed ID: 23068710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy for local control of osteosarcoma.
    DeLaney TF; Park L; Goldberg SI; Hug EB; Liebsch NJ; Munzenrider JE; Suit HD
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):492-8. PubMed ID: 15667972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials.
    Imai R; Kamada T; Tsuji H; Sugawara S; Serizawa I; Tsujii H; Tatezaki S;
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1470-6. PubMed ID: 19939576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon ion radiation therapy improves the prognosis of unresectable adult bone and soft-tissue sarcoma of the head and neck.
    Jingu K; Tsujii H; Mizoe JE; Hasegawa A; Bessho H; Takagi R; Morikawa T; Tonogi M; Tsuji H; Kamada T; Yamada S;
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2125-31. PubMed ID: 21745719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of radiotherapy in oseosarcoma.
    Schwarz R; Bruland O; Cassoni A; Schomberg P; Bielack S
    Cancer Treat Res; 2009; 152():147-64. PubMed ID: 20213389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma.
    Blattmann C; Oertel S; Schulz-Ertner D; Rieken S; Haufe S; Ewerbeck V; Unterberg A; Karapanagiotou-Schenkel I; Combs SE; Nikoghosyan A; Bischof M; Jäkel O; Huber P; Kulozik AE; Debus J
    BMC Cancer; 2010 Mar; 10():96. PubMed ID: 20226028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particle Therapy Using Protons or Carbon Ions for Unresectable or Incompletely Resected Bone and Soft Tissue Sarcomas of the Pelvis.
    Demizu Y; Jin D; Sulaiman NS; Nagano F; Terashima K; Tokumaru S; Akagi T; Fujii O; Daimon T; Sasaki R; Fuwa N; Okimoto T
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):367-374. PubMed ID: 28463156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma.
    Hundsdoerfer P; Albrecht M; Rühl U; Fengler R; Kulozik AE; Henze G
    Eur J Cancer; 2009 Sep; 45(14):2447-51. PubMed ID: 19596190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 1 trial of preoperative, short-course carbon-ion radiotherapy for patients with resectable pancreatic cancer.
    Shinoto M; Yamada S; Yasuda S; Imada H; Shioyama Y; Honda H; Kamada T; Tsujii H; Saisho H;
    Cancer; 2013 Jan; 119(1):45-51. PubMed ID: 22744973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical and functional outcome between surgical treatment and carbon ion radiotherapy for pelvic chondrosarcoma.
    Outani H; Hamada K; Imura Y; Oshima K; Sotobori T; Demizu Y; Kakunaga S; Joyama S; Imai R; Okimoto T; Naka N; Kudawara I; Ueda T; Araki N; Kamada T; Yoshikawa H
    Int J Clin Oncol; 2016 Feb; 21(1):186-93. PubMed ID: 26150259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
    Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon ion radiotherapy for inoperable pediatric osteosarcoma.
    Mohamad O; Imai R; Kamada T; Nitta Y; Araki N;
    Oncotarget; 2018 May; 9(33):22976-22985. PubMed ID: 29796166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon-ion radiotherapy of spinal osteosarcoma with long-term follow.
    Zhang W; Tanaka M; Sugimoto Y; Takigawa T; Ozaki T
    Eur Spine J; 2016 May; 25 Suppl 1():113-7. PubMed ID: 26298480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
    Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
    J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.